UK Drug Discovery Funding Rounds 2021

Every UK Drug Discovery funding round filed in 2021, sourced direct from Companies House filings. Updated weekly.

UK Drug Discovery Funding Rounds 2021

CompanyRaisedRoundDate
Stingray Bio£200k-2022/10/04
Graegis Pharmaceuticals£1.9MSeries A2022/01/21
Grey Wolf Therapeutics£29.3M-2022/01/14
Nodthera£12.1MSeries B2021/12/31
Askbio Uk£3.0M-2021/12/24
4c Biomed£1.2M-2021/12/19
Gylden Pharma£3.7M-2021/12/06
Medimab Biotherapeutics£200k-2021/11/29
Mitorx Therapeutics£1.6M-2021/11/26
Achieve Pharma Uk£2.3M-2021/11/23
Enedra Therapeutics£142k-2021/11/19
Loqus23 Therapeutics£6.9M-2021/11/19
Pheno Therapeutics£2.5MSeries A2021/11/15
Cc Biotech£28k-2021/11/15
Trx Biosciences£700k-2021/11/11
Pathios Therapeutics£694.8MSeries A2021/11/10
Epidarex Exeed£2835006.9M-2021/11/09
Kaerus Bioscience£201kSeries A2021/11/02
Blue Earth Therapeutics£12k-2021/11/02
Tay Therapeutics£1.6M-2021/11/01
Healome Therapeutics£151k-2021/10/27
Astellas Engineered Small Molecules U.K.£90k-2021/10/26
Glamorous Ai£60k-2021/10/19
Redx Pharma£175k-2021/10/15
Grey Wolf Therapeutics£3.6MSeries A2021/10/12

Sign up to see all uk drug discovery funding rounds 2021

+73 more rounds

Sign up

More Drug Discovery funding